| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 大消费类(元) | 699,783.86 | 3,515,467.94 | 2,161,180.21 | 5,925,359.79 | 3,527,661.72 |
| 固体类(元) | 12,148,565.03 | 27,351,505.13 | 14,202,523.72 | 26,763,850.89 | 10,312,139.77 |
| 客户肽(元) | 39,778,338.71 | 28,579,405.68 | 4,623,455.17 | 6,177,448.32 | 2,563,042.13 |
| 器械类(元) | - | - | - | 1,306,318.61 | 656,761.08 |
| 原料药(元) | 546,315,386.27 | 438,085,891.07 | 171,976,999.19 | 259,895,285.34 | 113,113,719.47 |
| 制剂(元) | 64,950,770.58 | 430,194,761.14 | 339,625,221.00 | 247,133,876.44 | 102,697,238.64 |
| 其他(补充)(元) | 24,393,776.85 | - | 16,852,727.50 | - | 22,850,011.33 |
| 营业成本(元) | |||||
| 大消费类(元) | 563,873.19 | 2,148,896.78 | 1,287,140.90 | 3,060,958.95 | 1,758,502.87 |
| 固体类(元) | 11,339,858.12 | 25,873,510.39 | 13,052,073.11 | 22,397,454.77 | 8,192,781.96 |
| 客户肽(元) | 15,132,426.61 | 15,669,665.88 | 1,341,842.14 | 1,856,881.11 | 783,997.76 |
| 器械类(元) | - | - | - | 2,296,712.11 | 1,110,032.59 |
| 原料药(元) | 177,805,967.61 | 148,292,616.98 | 39,863,431.16 | 67,689,741.07 | 30,474,694.95 |
| 制剂(元) | 39,692,523.66 | 187,208,158.43 | 143,931,315.52 | 128,104,388.30 | 48,653,861.71 |
| 其他(补充)(元) | 10,725,605.52 | - | 6,768,058.49 | - | 11,094,319.40 |
| 毛利(元) | |||||
| 大消费类(元) | 135,910.67 | 1,366,571.16 | 874,039.31 | 2,864,400.84 | 1,769,158.85 |
| 固体类(元) | 808,706.91 | 1,477,994.74 | 1,150,450.61 | 4,366,396.12 | 2,119,357.81 |
| 客户肽(元) | 24,645,912.10 | 12,909,739.80 | 3,281,613.03 | 4,320,567.21 | 1,779,044.37 |
| 器械类(元) | - | - | - | -990,393.50 | -453,271.51 |
| 原料药(元) | 368,509,418.66 | 289,793,274.09 | 132,113,568.03 | 192,205,544.27 | 82,639,024.52 |
| 制剂(元) | 25,258,246.92 | 242,986,602.71 | 195,693,905.48 | 119,029,488.14 | 54,043,376.93 |
| 其他(补充)(元) | 13,668,171.33 | - | 10,084,669.01 | - | 11,755,691.93 |
| 毛利率(%) | |||||
| 大消费类(%) | 19.42 | 38.87 | 40.44 | 48.34 | 50.15 |
| 固体类(%) | 6.66 | 5.40 | 8.10 | 16.31 | 20.55 |
| 客户肽(%) | 61.96 | 45.17 | 70.98 | 69.94 | 69.41 |
| 器械类(%) | - | - | - | -75.82 | -69.02 |
| 原料药(%) | 67.45 | 66.15 | 76.82 | 73.95 | 73.06 |
| 制剂(%) | 38.89 | 56.48 | 57.62 | 48.16 | 52.62 |
| 其他(补充)(%) | 56.03 | - | 59.84 | - | 51.45 |
| 收入构成(%) | |||||
| 大消费类(%) | 0.10 | 0.38 | 0.39 | 1.08 | 1.38 |
| 固体类(%) | 1.77 | 2.95 | 2.58 | 4.89 | 4.03 |
| 客户肽(%) | 5.78 | 3.08 | 0.84 | 1.13 | 1.00 |
| 器械类(%) | - | - | - | 0.24 | 0.26 |
| 原料药(%) | 79.37 | 47.22 | 31.30 | 47.50 | 44.23 |
| 制剂(%) | 9.44 | 46.37 | 61.81 | 45.16 | 40.16 |
| 其他(补充)(%) | 3.54 | - | 3.07 | - | 8.94 |
| 毛利构成(%) | |||||
| 大消费类(%) | 0.03 | 0.25 | 0.25 | 0.89 | 1.15 |
| 固体类(%) | 0.19 | 0.27 | 0.34 | 1.36 | 1.38 |
| 客户肽(%) | 5.69 | 2.35 | 0.96 | 1.34 | 1.16 |
| 器械类(%) | - | - | - | -0.31 | -0.29 |
| 原料药(%) | 85.10 | 52.83 | 38.49 | 59.73 | 53.78 |
| 制剂(%) | 5.83 | 44.30 | 57.02 | 36.99 | 35.17 |
| 其他(补充)(%) | 3.16 | - | 2.94 | - | 7.65 |